Cargando…
吉西他滨单药/或联合铂类与紫杉类单药/或联合铂类不同顺序治疗晚期肺鳞癌的疗效与安全性
BACKGROUND AND OBJECTIVE: Gemcitabine and taxanes are effective agents commonly used in advanced squamous lung cancer. The best treatment sequence, however, is unclear to our knowledge. So we conducted this retrospective study in order to compare the efficacy and toxicities of first-line Gemcitabine...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015219/ https://www.ncbi.nlm.nih.gov/pubmed/25975302 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.05.09 |
Ejemplares similares
-
吉西他滨联合铂类两药方案与单药方案对非小细胞肺癌治疗比较的meta分析
Publicado: (2010) -
培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta分析
Publicado: (2011) -
培美曲塞单药或联合铂类三线及以上治疗晚期非鳞型非小细胞肺癌的临床观察
Publicado: (2012) -
铂类联合多西他赛或长春瑞滨一线治疗晚期非小细胞肺癌的meta分析
Publicado: (2014) -
紫杉醇脂质体单药与紫杉醇脂质体联合奥沙利铂一线治疗老年晚期非小细胞肺癌的随机对照研究
Publicado: (2012)